Literature DB >> 2878736

Fibrinogen and fibrin: biochemistry and pathophysiology.

A Z Budzynski.   

Abstract

Fibrinogen is a thrombin-coagulable glycoprotein occurring in the blood of vertebrates. The primary structure of the alpha, beta, and gamma polypeptide chains of human fibrinogen is known from amino acid and nucleic acid sequencing. The intact molecule has a trinodular, dimeric structure and is functionally bivalent. Thrombin cleaves short peptides from the amino termini of the alpha and beta chains exposing polymerization sites that are responsible for the formation of fibrin fibers and appearance of a clot. The major physiological function of fibrinogen is the formation of fibrin that binds together platelets and some plasma proteins in a hemostatic plug. In pathological situations, the network entraps large numbers of erythrocytes and leukocytes forming a thrombus that may occlude a blood vessel. Fibrinogen and fibrin are multifunctional proteins. Fibrinogen is indispensable for platelet aggregation; it also binds to several plasma proteins, however, the biological function of this interaction is not completely understood. Fibrin is an essential matrix for regulation of fibrinolysis and for facilitation of cell attachment in wound healing.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878736     DOI: 10.1016/s1040-8428(86)80019-1

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

Review 1.  Natural responses to unnatural materials: A molecular mechanism for foreign body reactions.

Authors:  L Tang; J W Eaton
Journal:  Mol Med       Date:  1999-06       Impact factor: 6.354

Review 2.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

3.  Cl- regulates the structure of the fibrin clot.

Authors:  E Di Stasio; C Nagaswami; J W Weisel; E Di Cera
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

4.  The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.

Authors:  Y Veklich; E K Ang; L Lorand; J W Weisel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.

Authors:  R Pannell; J Black; V Gurewich
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 6.  Emerging biomarkers for the detection of cardiovascular diseases.

Authors:  Sreenu Thupakula; Shiva Shankar Reddy Nimmala; Haritha Ravula; Sudhakar Chekuri; Raju Padiya
Journal:  Egypt Heart J       Date:  2022-10-20

7.  Relative quantification of several plasma proteins during liver transplantation surgery.

Authors:  Ville Parviainen; Sakari Joenväärä; Eija Tukiainen; Minna Ilmakunnas; Helena Isoniemi; Risto Renkonen
Journal:  J Biomed Biotechnol       Date:  2011-12-10

8.  Fibrin clots are equilibrium polymers that can be remodeled without proteolytic digestion.

Authors:  Irina N Chernysh; Chandrasekaran Nagaswami; Prashant K Purohit; John W Weisel
Journal:  Sci Rep       Date:  2012-11-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.